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Objective: Short chain fatty acids (SCFAs) derived from dietary ﬁber fermentation by gut microbiota
have been identiﬁed as one of the mechanisms behind the association between habitual whole-
grain intake and a lower risk of cardiometabolic diseases. The aims of the present work are: (1)
to evaluate whether a whole-grain wheat-based diet may increase SCFAs concentration, and (2) to
identify possible associations between SCFAs and metabolic changes observed after the nutritional
intervention.
Methods: Fifty-four subjects participated in the trial. They underwent a 12-wk dietary intervention
based on whole-grain or reﬁned cereal products. At baseline and after the intervention, glucose,
insulin, triacylglycerol, inﬂammatory markers (hs-CRP, IL-1 ra, IL-6, and TNF-a), and SCFAs plasma
concentrations were evaluated.
Results: After the intervention, in the whole-grain group fasting plasma propionate concentrations
were higher than at baseline, whereas a reduction was detected in the control group. The absolute
changes (end of trial minus baseline) in fasting plasma propionate concentrations were signiﬁ-
cantly different between the two groups (P ¼ 0.048). The absolute changes of fasting propionate
correlated with cereal ﬁber intake (r ¼ 0.358, P ¼ 0.023), but no signiﬁcant correlations with
clinical outcomes were found. However, postprandial insulin was signiﬁcantly decreased in the
group having the absolute changes of fasting propionate concentration above the median value
(P ¼ 0.022 versus subjects with fasting propionate changes below the median value).
Conclusions: A 12-wk whole-grain wheat-based diet increases fasting plasma propionate. This
increase correlates with the cereal ﬁber intake and is associated with lower postprandial insulin
concentrations.
 2016 Elsevier Inc. All rights reserved.on in the sixth Framework
-514008) and Ministero
, Italy (PRIN n. 2010 JC
some of the cereal prod-
: þ39 81 7462321.Introduction
Whole-grain consumption has been associated with a
reduced risk of cardiovascular disease, overweight/obesity and
type 2 diabetes [1,2].
One of the proposedmechanisms behind these associations is
the colonic fermentation of cereal ﬁber, leading to the produc-
tion of short chain fatty acids (SCFAs): acetate, propionate, and
butyrate. In fact, many studies have speculated on the role of
SCFAs in the modulation of glucose and lipid metabolism [3,4].
Nevertheless, evidence from clinical trials is still scant and
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variability of ﬁber fermentation by colonic microbiota. In vitro [9,
10] and in vivo [4] studies have demonstrated that the rate of
ﬁber fermentation depends strictly on the type of cereal; in
particular, rye and barley seem to be more fermentable than
wheat. Moreover, study duration may also play a role. In fact,
Freeland et al. [11] have shown that wheat also increases colonic
SCFAs production, even though it takes time to be able to
appreciate a signiﬁcant increase of ﬁber fermentation products
in plasma (9 mo).
Thus, the aim of this study was to evaluate whether a 12-wk
consumption of a diet rich in whole-grain products (mainly
whole wheat) may inﬂuence the production of SCFAs in subjects
with the metabolic syndrome. In addition, we hypothesized a
role of SCFAs in the modulation of postprandial glucose, insulin,
and triacylglycerol concentrations and subclinical inﬂammation.
Material and methods
Subjects and study design
Fifty-four overweight/obese subjects (23 men and 31 women) with the
metabolic syndrome were randomly assigned to an isoenergetic diet based on
either whole-grain cereal products (whole-grain group, n ¼ 26) or reﬁned cereal
goods (control group, n ¼ 28) for 12-wk.
Details on the study design have been published elsewhere [12]. In short,
participants were encouraged not to change their habitual meat, dairy products,
eggs, ﬁsh, fruit, vegetable, and fat intake during the study. The only difference
between thewhole-grain and the control diet was the inclusion of a ﬁxed amount
of whole-grain or reﬁned cereal products as the main carbohydrate source.
Therefore, the two diets were designed to have the same energy intake and
nutrient composition (18% protein, 30% fat, 52% carbohydrates); they were
different only for cereal-foods consumed and for the cereal ﬁber intake.
At baseline and at the end of the intervention, fasting blood samples were
taken in K2-EDTA tubes for SCFAs measurements and fasting and postprandial
blood samples (over 3 h) for the evaluation of glucose, insulin, triacylglycerol, and
inﬂammatory markers (hs-CRP, high-sensitivity C-reactive protein; IL-6, inter-
leukin-6; IL-1 ra, interleukin-1 receptor antagonists; and TNF-a: tumor necrosis
factor-a). During the study, all subjects were asked to ﬁll in a 7 d food record
every mo to assess dietary compliance.
The design of the trial was approved by the “Federico II” University Ethics
Committee and followed the Helsinki Declaration guidelines. All participants
provided written informed consent.
The study was registered with ClinicalTrials.gov (identiﬁer NCT00945854).
Experimental procedures
Plasma glucose and triacylglycerol concentrations were assayed by
enzymatic colorimetric methods (ABX Diagnostics, Montpellier, France; RocheTable 1
Clinical data, fasting plasma metabolic parameters and inﬂammatory markers at base
Parameters Control group (n ¼ 19)
Baseline 12 week D
Age (years) 58.4  1.6
Sex (M/F) 7/12
BMI (kg/m2) 31.5  1.3 31.3  1.3 0.20  0.2
Fasting glucose (mg/dL) 105  2.8 105  0.2 0.72  1.5
Fasting insulin (mU/mL) 11.8  1.3 11.7  1.6 0.11  1.5
HOMA 3.08  0.3 3.09  0.5 0.01  0.4
Triacylglycerols (mg/dL) 133  9.5 136  13 2.95  12
Total cholesterol (mg/dL) 201  8.8 208  7.5 6.47  5.0
HDL-cholesterol (mg/dL) 38.7  1.5 39.8  1.5 1.11  1.2
hs-CRP (mg/dL) 2.27  0.4 2.39  0.4 0.12  0.2
IL-6 (pg/mL) 1.69  0.3 1.70  0.3 0.01  0.2
IL-1 ra (pg/mL) 316  73 311  63 5.17  14
TNF-a (pg/mL) 1.07  0.4 1.31  0.5 0.24  0.1
BMI, body mass index; HDL, high-density lipoproteins; hs-CRP, high-sensitivity C-r
receptor antagonists; IL-6, interleukin-6; TNF-a, tumor necrosis factor-a; ANOVA, ana
Data are expressed as mean  SEMMolecular Biochemicals, Mannheim, Germany; Wako Chemicals GmbH, Neuss,
Germany, respectively) on a Cobas Mira autoanalyzer (ABX Diagnostics,
Montpellier, France). Plasma insulin concentrations were measured by an
enzyme-linked immunosorbent assay for the speciﬁc determination of biologi-
cally active insulin (DAKO Insulin, DAKO Diagnostics, Ely, UK). The inﬂammatory
markers (hs-CRP, IL-1 ra, IL-6, and TNF-a) were determined in Germany at the
University of Ulm, in the laboratory of the Department of Internal Medicine
II-Cardiology, as described by de Mello et al. [13].
Acetate, propionate, and butyrate acids were evaluated in plasma at baseline
and at the end of the dietary intervention. Before the analyses, 400 mL-samples
were deproteinated using 50 mL metaphosphoric acid (16% W/V) at 60 C for
30 min and 50 ml of internal standard (isovaleric acid 80 mM) was added to each
sample. After centrifugation (8000 rpm for 30 min at room temperature) all
samples were ﬁltered. Then, SCFAs concentrations were analyzed by
gas-chromatography (Hewlett Packard 5890 Series II), according to Remesey and
Demigne [14].Statistical analyses and calculations
Results were expressed as mean  SEM. Variables not normally distributed
were analyzed after logarithmic transformation or as medians.
To test the effects in each intervention group, 12-wk concentrations were
compared to the baseline concentration by a paired sample t test. Differences
between the two experimental diets, expressed as absolute changes (12-wk value
minus baseline value) were evaluated by one-way analysis of variance (ANOVA).
Bivariate associations were assessed by Pearson’s correlation. A P value <0.05
was considered signiﬁcant. Statistical analysis was performed according to
standard methods using the Statistical Package for Social Sciences software
version 21.0 (SPSS, Chicago, IL, USA).Results
Subjects characteristics and dietary compliance
SCFAs measurement was performed in 40 subjects who were,
therefore, included in this analysis: 19 subjects (7 M/12 F) in the
control group and 21 subjects (9 M/12 F) in the whole grain
group. The two experimental groups were similar at baseline for
anthropometric parameters as well as for all clinical and
metabolic parameters and inﬂammatory markers (Table 1). A
signiﬁcant reduction of postprandial insulin and triacylglycerol
responses were observed at the end of the intervention in the
whole-grain group compared to the control group (postprandial
insulin: 17.2  10 versus 13.6  6.7 mU/mL, whole grain and
control group respectively, P < 0.05; postprandial triacylglycer-
ols:22.6 13 versus 11.6  8.9 mg/dL, whole-grain and control
group respectively, P < 0.05) [12].line and after the intervention in the two experimental groups
Whole-grain group (n ¼ 21) ANOVA for D
Baseline 12 week D
57.2  1.9
9/12
32.1  1.4 31.9  1.4 0.20  0.2 0.992
103  2.2 103  2.7 0.38  1.7 0.882
14.1  1.9 13.3  1.1 0.47  0.9 0.726
3.61  0.5 3.36  0.3 0.25  0.3 0.615
153  36 137  15 16.9  28 0.538
200  10 201  10 1.10  5.1 0.457
42.9  3.2 42.3  3 0.62  1.2 0.324
2.52  0.5 2.44  0.5 0.08  0.4 0.693
1.84  0.2 2.23  0.3 0.39  0.2 0.161
380  61 378  61 1.40  24 0.897
1.71  0.6 1.50  0.6 0.21  0.3 0.232
eactive protein; HOMA, homeostasis model assessment; IL-1 ra, interleukin-1
lysis of variance
Table 2
Fasting concentrations of plasma acetate, propionate and butyrate measured in the two experimental groups
SCFA (mmol/L) Control group (n ¼ 19) Whole-grain group (n ¼ 21) ANOVA for D
Baseline 12 week D Baseline 12 week D
Acetate 204  20 178  20 26.1  18 179  14 154  18 25.2  20 0.974
Propionate 7.58  1.1 6.29  0.9 1.30 ± 0.9 5.61  0.6 7.11  0.9 1.50 ± 1.0 0.048
Butyrrate 5.58  0.9 5.69  0.9 0.11  0.7 4.37  0.6 4.74  0.6 0.37  0.7 0.623
Data are expressed as mean  SEM
Bold values are used to highlight statistically signiﬁcant results
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(Table 1).
As reported earlier [12], no differences were observed in diet
composition at baseline between the two experimental groups.
During the intervention, dietary compliance was adequate
according to the 7-d food records in both groups. Total and cereal
ﬁber intake were signiﬁcantly different between the two
experimental groups at the end of the trial, as expected from the
controlled study design (total ﬁber: 40.2  1.2 versus
22.1  0.9 g/d whole-grain and control group respectively,
P < 0.001; cereal ﬁber: 28.9  1.1 versus 11.8  0.4 g/d, whole-
grain and control group respectively, P < 0.001). Moreover, we
found a signiﬁcant difference in the absolute change of total
plasma alkylresorcinol concentrations, a well-known marker of
whole-wheat intake [15], between the two experimental groups
(88.3  16 versus 19.7  7.0 nmol/L, whole-grain and control
group, respectively P < 0.001). No other signiﬁcant differences
were observed between the two study groups in relation to the
energy content and nutrient composition of the diet during the
trial [12].Short chain fatty acids concentrations
The concentrations of SCFAs detected at baseline and after the
experimental period are shown in Table 2.
Fasting plasma concentrations of acetate, propionate, and
butyrate were similar in both groups at baseline. After the
intervention, fasting plasma propionate concentration increased
in respect to baseline in the whole grain group, whereas a
reduction was detected in the control group. Consequently, the
absolute changes in fasting plasma propionate concentration
between 12 wk and the baseline values were signiﬁcantly
different between the whole grain and the control group
(þ1.50  1.0 versus 1.30  0.9 mmol/L, respectively; P ¼ 0.048;
Table 2).Fig. 1. Pearson correlation between the absolute changes (end of the trial minus
baseline) of cereal ﬁber intake and fasting propionate. Black circle, control group;
white circle, whole-grain group.Short chain fatty acids and clinical outcomes
At the end of the intervention, the absolute change in fasting
plasma propionate concentrationwas positively and signiﬁcantly
correlated with the cereal ﬁber intake (r ¼ 0.358, P ¼ 0.023)
(Fig. 1).
No signiﬁcant correlations were found between fasting SCFAs
concentrations and clinical outcomes. Nevertheless, when the
groups were stratiﬁed according to the absolute changes
between the end of the trial and baseline of fasting plasma
propionate (median value: 0.0500 mmol/L), we found a lower
average postprandial plasma insulin concentration in the
group above the median than in the group below the
median value (17.4 versus 12.4 mU/mL, respectively; P ¼ 0.022,
Fig. 2).Discussion
In this study, we detected an increase in fasting propionate
plasma levels after 12-wk consumption of a diet rich in
whole-grain foods. In addition, this increase was positively
correlated with the cereal ﬁber intake. This ﬁnding is strength-
ened by the optimal compliance to the recommended diets
assessed by plasma alkylresorcinol concentrations, a marker of
whole-wheat intake as reported above.
These results suggest that also ﬁber present in whole-grain
wheat foods, like that present in other cereal foods, can be fer-
mented and induce a modiﬁcation of colonic microbiota in the
time frame of 12 wk.
In the study of Freeland et al. [11], SCFAs production was
detectable only after 9 mo of wheat consumption, even if the
amount of dietary ﬁber was equal to that provided by our
experimental diet (40.0 versus 40.2 g/d, respectively).
In our study, correlation analyses did not show any relation
between fasting propionate and metabolic parameters or
inﬂammatory makers. However, if the study population was
stratiﬁed according to the median value of the absolute change
(end of the trial minus baseline) of plasma propionate
Fig. 2. Mean postprandial insulin increment according to the absolute changes (end of the trial minus baseline) of plasma fasting propionate (below and above the median).
Data are expressed as mean  SEM. Black, values below the median; white, values above the median. *P ¼ 0.020 (versus below the median; one-way ANOVA).
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in subjects above the median value when compared to subjects
below the median. This result is in line with other studies
evaluating the effect of propionate-enriched cereal products on
postprandial insulin response [16–19].
In our trial we did not observe any improvement of
peripheral insulin sensitivity (evaluated by IVGTT-derived
indices), therefore, we assumed that the reduction of post-
prandial insulin was a marker of improved insulin sensitivity
at the splanchnic level. Propionate is produced by colonic
fermentation and, after intestinal absorption, it reaches the
liver where it is metabolized. Therefore, we can hypothesize
that a higher propionate production in the colon during the
whole-grain diet may have improved insulin action specif-
ically at the level of the liver.
Unfortunately, we did not perform any measurement of he-
patic insulin sensitivity. However, Luo et al. [20] demonstrated
that a 4-wk consumption of short-chain fructooligasaccharides, a
high-fermentable ﬁber, reduces hepatic glucose production in
healthy subjects, which is in linewith an improvement of hepatic
insulin sensitivity.
Undoubtedly, dietary strategies to modulate the postprandial
insulin response are necessary tools in the management and
prevention of cardiometabolic diseases. In this light, the results
of our trial, in agreement with the evidence available in the
literature, suggest that habitual whole wheat consumption may
help to achieve this goal.
One limitation of our study is the assessment of SCFAs in
peripheral blood, which did not allow us to evaluate the amount
of SCFAs reaching the liver (this represents the major site of their
effects).
The assessment of fecal SCFAs would have been helpful to
evaluate the extent of colonic fermentation in the two
experimental groups; unfortunately, fecal samples were not
collected. Moreover, we have no information on colonic
microbiota composition.
In addition, we cannot exclude that the sample size and the
study duration were not sufﬁcient to detect signiﬁcant
correlations between SCFAs and clinical outcomes.The strengths of our study are the well-controlled study
design, the optimal compliance to the experimental diets of the
participants and the prolonged exposure to a rather high
consumption of whole grain wheat products.
Conclusion
The habitual consumption of whole grain wheat foods may
promote colonic ﬁber fermentation, as suggested by the increase
of fasting propionate concentrations observed in thewhole-grain
group at the end of the dietary intervention. In addition, propio-
nate may be involved in the reduction of postprandial insulin
concentrations observed after the whole-grain diet. Further
studies are needed to clarify this effect, meanwhile, this study
adds new information on the potential beneﬁts of whole-grain
consumption in line with present dietary recommendations.
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